Category : Vitamin Research

Health Products Holdings has acquired … – Nature’s Products

Sunrise, FL ( August 31st, 2015) Health Products Holdings, LLC (HPH) has acquired from Vitamin Research Products, LLC all of its brands and related assets, including the well-known direct-to-consumer brands Vitamin Research Products (VRP), True Health (TH), and Health Resources (HR).

All three brands complement HPHs existing direct-to-consumer portfolio of brands, which included Iceland Health, Blessed Herbs, and Nutri-Health Supplements.

VRP brings market-leading products and significant talent that will partner well with our current brands, and provide customers exciting new choices to meet their specific health needs, now and in the future, said Tom Callahan, President of the direct-to-consumer business for HPH.

The entire VRP marketing team is thrilled to be joining forces with HPH. We look forward to multiple opportunities to grow our brands and build our leadership position in the direct-to-consumer nutritional supplement industry, said Kelly Cleary, formerly with VRP and now VP of Direct-to-Consumer Marketing for the combined business.

Added Mike Burroughs, now VP of IS and Digital Marketing, I believe VRP will benefit greatly from the additional financial and operational resources HPH will provide. We are very excited about the growth potential of our new, combined business.

HPHs direct-to-consumer team now combines some of the very best national talent in the industry across the catalog and digital marketing space with over a century of cumulative experience in direct-to-consumer marketing, hundreds of thousands of active customers, and over 400 unique supplement formulations to serve them.

This is the second acquisition in the past 10 months for Health Products Holdings as it continues to aggressively strengthen capabilities and expand its branded product portfolio across different areas of the nutritional supplements market, covering a broad portfolio of products across all channels.

About Health Product Holdings, LLC

Health Products Holdings, LLC, previously known as Natures Products, Inc., was founded in 1986 as a full service, GMP certified, contract manufacturer of consumer healthcare products in Sunrise, Florida. In addition to contract manufacturing, HPH now owns, produces, and markets its own portfolio of brands including Rainbow Light, Champion Nutrition, Iceland Health, Nutri-Health Supplements, Sedona Labs, Sedona Pro, Blessed Herbs and VitalStyle. HPH currently employs over 400 employees and offers a wide range of formulations, dosage forms, and manufacturing and packaging capabilities. Also, HPH has several affiliated businesses globally that expand the breadth of its capabilities and dosage forms beyond the nutritional supplement area. More information about Health Product Holdings can be found at http://www.hph-llc.com.

About Vitamin Research Products

Since Vitamin Research Products opened their doors in 1979, their mission has been to deliver the finest nutritional supplements and empower their customers to take charge of their own health. Every supplement offered by Vitamin Research Products (VRP) is developed and vetted by a staff of physicians, PhDs, nutritionists and individuals with decades of experience in product formulation. To ensure the best quality, all products are made with a careful selection of raw materials and comply with Current Good Manufacturing Practices (CGMPs). Vitamin Research Products merged with Health Resources and True Health in 2010. For more information on the brands of Vitamin Research Products, please visit their websites at http://www.vrp.com, http://www.truehealth.com, and http://www.healthresources.net.

Go here to read the rest:
Health Products Holdings has acquired … – Nature’s Products

Recommendation and review posted by Alexandra Lee Anderson

Carson City nutrition factory to collaborate education with products – Nevada Appeal

Maria Watson wants Carson City to know she’s back in business and is determined to bring the community quality health education, along with the relaunch of her company.

Formerly known as Vitamin Research Products, the CEO and president is reintroducing her natural vitamin supplement line as American Nutritional Products after a two year hiatus.

From stress relievers to belly busters, Watson’s multivitamin products are manufactured with formulas containing plant-based ingredients, FDA approved.

Now that she’s returned, she hopes to connect with the local community such as schools, churches, and other organizationsto teach the benefits of a healthy lifestyle and how to achieve it, while promoting her product.

Specifically, she hopes to target families and single parents, as nearly a third of the country spends dollars on fast-food and restaurant services, according to USDA.

Whether seminars take place at community colleges, health centers, or even at her facility, Watson hopes to fulfill one’s health goals and produce new jobs in the area.

“It’s been a painful and long journey,” she said. “But this community helped us the first time and I want to educate as a way to give back.”

When her company used to be Vitamin Research, Watson and her husband, Ron, supervised the facility on Highway 50 East in 2012, before constructing a larger building at 4610 Arrowhead Drive.

Back then, the company employed 127 people and packaged at least 3,000 products per day.

However, regulatory climate became a concern, to a point where the private equity group supporting Watson’s company announced closure in July 2015. That closure led to the closure of Vitamin Research.

Now with 23 returning employees, Watson is preparing to get her manufacturing business up and running under the new name.

“My dream came true, but the rooms are empty.” she said.

As for Watson’s longtime customers, they’re elated over the news of the original founder’s return.

Jana Kay of Reno said she appreciates the natural ingredients the company uses in the multivitamins, as she couldn’t find desired quality products in grocery stores or pharmacies.

“She’s on a mission and wants to educate peoplewe need to educate people. That’s why I was inspired to study nutrition and psychology in college, and learn about eating disorders within mental health.”

Although Watson is a nutritional guru, what truly inspired her to get into the industry was her son, Josh, whom died at the age of 3 in 1987.

“He died in a car accident caused by a drunk driver, his babysitter,” she said. “When he died, I gained 199 pounds and went through depression. But I knew I couldn’t be like this foreverI believed I could change the world with my passion, and I still feel that way.”

Watson is developing a plan for international collaboration. She connected with Deborah Torres Patel, a high prolific communication coach based out of Singapore.

Patel is known for mentoring best selling authors, entrepreneurs and leaders of Fortune 500 companies, and numerous celebrities in 79 countries.

Patel has never been to Carson City until last month when she met with Maria to help her develop a draft on how to combine health and education within the company.

One of Watson’s ideas is to teach ways to relieve stress and anxietywith public speaking being a start.

“84 percent of first-time impressions is based on your tone of voice,” Patel said. “It also affects how you feel and that’s why I created my system to find your voice; you only get one chance to make a first impression.”

Patel and Watson also discussed ways to collaborate education with new products, such as consumables or water with a natural ingredients to support energy boosts.

“It’s about essential integrity and work,” Watson said. “Why not amplify that in Carson City? People that live here are active. I want to educate those that will listen.”

Watson advises the public to watch for future job announcements as the company grows.

For more information, contact Watson at 775-720-0028 or maria.watson@anp-nv.com.

Continue reading here:
Carson City nutrition factory to collaborate education with products – Nevada Appeal

Recommendation and review posted by Alexandra Lee Anderson

Vitamin Research – UNIV OF WISCONSIN

Progress 10/01/06 to 09/30/11

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas is described below. Project 1. Both nutritional and genetic approaches are being used to determine how vitamin A functions in developing embryos, neonates and adults. Our laboratory has developed animal models to study vitamin A function in both early and late embryonic processes, as well as during postnatal life. We have shown that vitamin A is required for the initiation of meiosis in both the female and male gonad. Additionally, we identified several retinoic acid responsive genes that are expressed in the nervous system of developing embryos and in the adult brain. One of these, neuron navigator 2 (Nav2 or retinoic acid-induced in neuroblastoma, RAINB1), plays an essential role in neurite outgrowth, and in the development of the cranial nerves, eye, and brain. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects. In collaboration with our colleagues at the OSU, we have shown that the carbon-linked 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), does not need to be hydrolyzed back to atRA to function in culture or in vivo. Mechanistic microarray studies are underway to determine how these compounds work in cultured breast cancer cells and mammary tumors. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of acne and other disease states. Using the Rhino mouse as a model, we have identified a unique subset of vitamin D analogs that induce comedolysis. Studies are underway to determine how vitamin D compounds act to produce these effects. PARTICIPANTS: Jamie Ahrens (Senior research specialist), Elizabeth McNeill (Research associate), Danielle Knutsion (Research associate), Allyson Anding (Research assistant), Melissa Rohrer (Research associate), Mark Marzinke (Research assistant), Nirca Nieves (Research associate), Jim James (Associate research specialist), Mariana Bormann (Associate research specialist) TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: Not relevant to this project.

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. Rather than striving only to prevent overt nutrient deficiency, we need to begin to develop an understanding of “optimal” levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus, studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

Progress 01/01/09 to 12/31/09

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas is described below. Project 1. Both nutritional and genetic approaches are being used to determine how and when vitamin A is needed for developing embryos, neonates and adults. Our laboratory has developed methods that enable the study of vitamin A function in both early and late embryonic processes, and more recently during postnatal life. When limiting amounts of atRA are provided after embryonic day (E) 10.5 in the rat, a highly reproducible and penetrant state of late fetal vitamin A-deficiency (VAD) is produced in the organs of developing fetuses. Using this method, we have recently shown that vitamin A is required for the initiation of meiosis in the female gonad. In addition, we have published a detailed characterization of the molecular events that are perturbed in the developing eye when insufficient vitamin A is present. We are also studying the function of several novel atRA responsive genes, and have shown that one of these genes (RAINB1 also known as Nav2) plays an essential role in neurite outgrowth, and in the development of the cranial nerves, eye, and brain. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects. In collaboration with our colleagues at the OSU, we have shown that the carbon-linked 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), does not need to be hydrolyzed back to atRA to function in culture or in vivo. Further, 4-HBR is less toxic than 4-HPR, and appears to act by inducing ER stress-mediated responses. Work to further elucidate the cellular pathways that are altered by 4-HBR is underway, as are studies of its effects in developing embryos. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of acne. Using the Rhino mouse as a model, the ability of compounds to produce a reduction in comedone size is being studied. Whereas all vitamin D analogs appear to induce thickening of the epidermis, we have identified a unique subset of analogs that also induce comedolysis. Studies are underway to determine how vitamin D compounds act to produce these effects. PARTICIPANTS: Angela See, Postdoctoral fellow; current employment Nimblegen; Hui Li, Postdoctoral fellow; Melissa Rohrer, Posdotoral fellow; Elizabeth McNeill, completed PhD; Nirca Nieves, completed PhD; Allyson Anding, PhD training ongoing; Mark Marzinke, PhD training ongoing TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: Not relevant to this project.

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. Rather than striving only to prevent overt nutrient deficiency, we need to begin to develop an understanding of “optimal” levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

Progress 01/01/08 to 12/31/08

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas are described below. Project 1. Both nutritional and genetic approaches are being used to determine how and when vitamin A is needed for developing embryos, neonates and adults. Our laboratory has developed methods that enable the study of vitamin A function in both early and late embryonic processes, and more recently during postnatal life. Our recently published work shows that when limiting amounts of atRA are provided after embryonic day (E) 10.5 in the rat, a highly reproducible and penetrant state of late fetal vitamin A-deficiency (VAD) is produced in the organs of developing fetuses. This work shows that a large number of organ systems are adversely affected, including the eye. The optic fissure does not close, and severe folding and collapse of the retina is observed at E18.5. In our most recent work, we show that coloboma and retinal folding represent distinct VAD-dependent effects. The downregulation of Pitx2 in VAD may be related to the failure of the optic fissure to close, whereas a reduction in cyclin D1 and the cell adhesion molecules, N-cadherin and B-catenin, may play a role in the retinal thinning, folding and collapse observed in late VAD fetuses. We are also studying the function of several novel atRA responsive genes, and have found that one of these genes (RAINB1) plays an essential role in neurite outgrowth, and in the development of the cranial nerves, eye, and brain. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects on cancer cells. In collaboration with our colleagues at the OSU, we have found that the carbon-linked 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), does not need to be hydrolyzed back to atRA to function in culture or in vivo. Our studies also indicate that 4-HBR is less toxic than 4-HPR. Recently, we reported that 4-HBR rapidly induces ER stress-mediated responses and this may represent a mechanism whereby this compound produces its chemotherapeutic effects. Work to further elucidate the cellular pathways that are altered by 4-HBR is underway. Studies of additional nonhydrolyzable compounds, including glucuronide and glucose derivatives of 4-HBR are also ongoing. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of acne. Using the Rhino mouse as a model, the ability of compounds to produce a reduction in comedone size is being studied. We have identified a specific subset of vitamin D analogs that are effective in this model. Studies are underway to determine how vitamin D compounds act to induce comedolysis. PARTICIPANTS: See – PhD received 2008: Knutson – PhD received 2008 Muley – completed postdoctoral training; McNeill – PhD in progress TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: Not relevant to this project.

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. It is becoming abundantly clear that rather than striving only to prevent overt nutrient deficiency, that we need to begin to develop an understanding of “optimal” levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

Progress 01/01/07 to 12/31/07

Outputs OUTPUTS: The overall focus of this work is the study of the fat-soluble vitamins A and D. Ongoing work in three project areas is described below. Project 1. Both nutritional and genetic approaches are being used to determine how and when vitamin A is needed for developing embryos. Our laboratory has developed methods that enable the study of vitamin A function in both early and late embryonic processes. Using this model, we have shown that vitamin A plays a critical early role in patterning the heart, hindbrain and axial skeleton. Our recently published work shows that when limiting amounts of atRA are provided after embryonic day 10.5 in the rat, a highly reproducible and penetrant state of late fetal vitamin A-deficiency (VAD) is produced in the organs of developing fetuses. These fetuses also display anteriorization of cervical regions of the skeleton and novel posteriorization events at the thoracic and sacral levels, and also show sternal and pelvic malformations not previously observed in genetic models. We are now using these nutritional models to explore the molecular mechanisms that are disrupted by embryonic vitamin A-deficiency. We are also studying the distribution and function of novel atRA responsive genes, and have found that one of these genes (RAINB1) plays an essential role in neurite outgrowth. Project 2. Cellular and in vivo approaches are being used to address how the 4-HPR analog, 4-hydroxybenzylretinone (4-HBR), exerts its antitumor effects on cancer cells. In collaboration with our colleagues at the OSU, we have found that the carbon-linked 4-HPR analog (4-HBR) does not need to be hydrolyzed back to atRA to function in culture or in vivo. Studies of the efficacy 4-HBR in chemotherapy of DMBA-induced mammary tumors in the rat show that the non-hydrolysable analog is equally effective in reducing tumor size and number, and does so without reducing blood retinol levels, an undesirable side affect associated with the use of the parent compound, 4-HPR. Although 4-HBR can bind and transactivate RARs, this is not required for it to induce cell death. Recently, we reported that 4-HBR rapidly induces ER stress-mediated responses and may represent a mechanism whereby this compound produces its chemotherapeutic effects. Project 3. Additional studies in the lab are directed at developing improved vitamin analogs for the treatment of disease. One example is the use of retinoids for the treatment of acne. A major limitation to current oral therapy is teratogenic liability. As a potential improvement, we are studying sterically hindered vitamin A analogs. Using the Rhino mouse as a model, the ability of compounds to produce a reduction in comedone size is being studied. We have also found that some vitamin D analogs are effective in this model. Studies are underway to determine whether these approaches may offer any advantage to existing therapies. PARTICIPANTS: J. Ahrens, Research Specialist M. Kaiser, Senior Research Specialist In Training E. McNeill, Research Asst A. See, Research Asst N. Nieves, Research Asst A. Anding, Research Asst D. Knutson, Research Asst TARGET AUDIENCES: Biochemical, Cellular and Molecular and Medical Research Communities, with the Intent of Increasing Knowledge, as well as, to Capitalize on the Translational Value of this Research.

Impacts The reproductive efficiency and health of animals, including humans, is clearly influenced by nutritional status. It is becoming abundantly clear that rather than striving only to prevent overt nutrient deficiency, that we need to begin to develop an understanding of “optimal” levels of a given nutrient to promote health. A detailed understanding of the physiological and molecular processes for which vitamins are needed is essential not only for optimizing human health, but also for determining how vitamin derivatives might be used in the treatment of human disease. For example, vitamin A compounds have shown promise in the prevention and treatment of cancer, as well as in the treatment of acne. However, the toxicity of many retinoids limits their use. Similar potential exists for the use of vitamin D analogs in a number of diseases, but the side effect, hypercalcemia, has been a major limitation to the advancement of these efforts. Thus studies of new vitamin A analogs and non-calcemic vitamin D analogs may offer new approaches to the treatment of several disease states, including acne and cancer. Numerous patents that have issued or have been filed through the Wisconsin Alumini Research Foundation have arisen from these studies.

Publications

The rest is here:
Vitamin Research – UNIV OF WISCONSIN

Recommendation and review posted by Alexandra Lee Anderson

What Do Your Tears Say About Your Health? – Chromatography Today

Some are happy, most are sad and others are just a result of chopping onions. Yes, tears. Psychiatrists could probably spend hours telling you what your tears mean for your mental health. But the little watery droplets are usually seen as fruitless for physical information. However, a team of scientists at Michigan Technological University may have changed that. Read on to see how tears can be used for medical testing.

Despite the perception of tears as empty and invaluable, they might contain important nutritional information. At present, the only way to access patients nutritional information, like vitamin levels, is through invasive (and expensive) blood tests. And it was this that led the team at Michigan Tech to their main question are there links between tear content and nutritional values in blood?

“We hypothesized that nutrients are transferred to the living cells of your cornea through your tears,” explains Michigan Tech research specialist Maryam Khaksari. “We would like to translate the information we have for blood to tears. The link is certainly possible, with previous studies finding people with vitamin deficiencies blink more than those without.

To test the link, they focussed on three vitamins A, B and E. After taking samples of the tears and blood from 15 babies aged four-months as well as their parents, they used liquid chromatography and mass spectrometry to assess the content of the samples. Improved analytical development for this method is explored in the article, Capillary Flow LC-MS Unites Sensitivity and Throughput.

Overall, the results showed that levels of fat-soluble vitamins were higher in parents, while water-soluble vitamins were seen more in babies. There was a connection between the vitamin levels in parents and babies, with a correlation between vitamins B and E also shown by the results.

However, whats more significant is the promise this research shows in using tears for vitamin research. In this paper, we did show that there are correlations between vitamin concentrations in tears and bloodso it’s possible,” says Khaksari. The next step is to develop a device capable of performing these tests.

This project was the first step that proved vitamins are detectable in tears, that they do correlate with blood levels. Next we want to engineer a portable, lab-on-a-chip device relying on a minimally invasive sample from tears to assess nutrition, said Adrienne Minerick, professor of chemical engineering at Michigan Tech.

Looks like our parents were wrong when they said crying wont help.

Excerpt from:
What Do Your Tears Say About Your Health? – Chromatography Today

Recommendation and review posted by Alexandra Lee Anderson

Vitamin Research Products, LLC: Private Company …

Vitamin Research Products, LLC manufactures and supplies herbal and nutritional supplements. Its products include botanicals and herbs, health interest formulas, minerals, specialty supplements, vitamins, and miscellaneous products. The company also offers anti-inflammatory, antioxidants, blood pressure, blood sugar, bone support, cholesterol, detoxification, digestive health, energy, hair/skin/nails, healthy aging and vitality, heart/cardiovascular, immune support, joint/muscle, memory/cognitive support, respiratory, stress/mood/sleep, thyroid health, vision, weight management, women’s health, men’s health, and multivitamin/multi-nutrient products. It sells its products through an online st…

Vitamin Research Products, LLC manufactures and supplies herbal and nutritional supplements. Its products include botanicals and herbs, health interest formulas, minerals, specialty supplements, vitamins, and miscellaneous products. The company also offers anti-inflammatory, antioxidants, blood pressure, blood sugar, bone support, cholesterol, detoxification, digestive health, energy, hair/skin/nails, healthy aging and vitality, heart/cardiovascular, immune support, joint/muscle, memory/cognitive support, respiratory, stress/mood/sleep, thyroid health, vision, weight management, women’s health, men’s health, and multivitamin/multi-nutrient products. It sells its products through an online store. The company was founded in 1979 and is based in Carson City, Nevada. As of 2005, Vitamin Research Products, LLC operates as a subsidiary of Argan, Inc.

4610 Arrowhead Drive

Carson City, NV89706

United States

Founded in 1979

Originally posted here:
Vitamin Research Products, LLC: Private Company …

Recommendation and review posted by Alexandra Lee Anderson

Vitamins Information Center – A comprehensive database of …

your source for the latest research on vitamins, minerals and whole-food nutrition

The Vitamins & Nutrition Center is a leading authority on vitamins, minerals and whole-food nutrition. Explore the latest research, detailed profiles on every vitamin and mineral, what to look for in a multivitamin, and thousands of informative articles on how to achieve and maintain a healthy lifestyle.

Vitamin Research Center We have gathered hundreds of published research on vitamins and presented them to you in plain English. See what the latest clinical research says about your favorite vitamins and the positive impact that vitamins can have on your health and disease prevention.

THE GREAT DEBATE: LIQUID VITAMINS VS. PILLS

What kind of vitamins should you be taking? Liquid form? Pill from? Decide for yourself.

HealthyLiving Blog Join the conversation on all things health-related.

Detailed information on the 46 most common vitamins, including Vitamin A, Vitamin B, Vitamin C, Vitamin D and Vitamin E. Minerals and many herbs are also profiled.

Learn More

We have gathered hundreds of published research on vitamins and presented them to you in plain English. See the latest clinical research.

Learn More

View original post here:
Vitamins Information Center – A comprehensive database of …

Recommendation and review posted by Alexandra Lee Anderson

Vitamin Research – All the latest research on Vitamins A …

We have gathered hundreds of published research on vitamins and presented them to you in plain English. See what the latest clinical research says about your favorite vitamins and the positive impact that vitamins have on disease prevention.

Thousands of new discoveries are made every single day, and you had better believe that no doctor has the time to keep up with all of the latest research, especially if they are a general practitioner and need to know about all of the body’s systems and keep up with what the latest drug reports are. Who has time to read up on vitamins? Also keep in mind – no drug rep will ever visit a doctor to sell them a vitamin. There just isnt any money in it. That doesn’t make vitamins any less valuable though. If nothing else, vitamins are one of the most beneficial supplements you could take. Literally hundreds of thousands of clinical studies on vitamins have been published, and the benefits of vitamins should not be ignored simply because nobody is directly selling them to you.

While a great many medical professionals read this site for information, we have “translated” every single of the hundreds of medical studies you see here into plain english so that the general public can – for the first time – be introduced to the latest cutting edge research that our world has discovered. With the power of the Internet, and the work of scores of people, this information is available to you completely free of charge.

Instead of wading through extremely thick and almost unintelligible clinical studies, or waiting ten or more years for research findings to reach your doctors office, take a look at what medical science has discovered now about your favorite vitamins and supplements. Feel free to print these out and show them to your medical professional, and ask them to do their own research. They may even learn a thing or two they did not know before. Remember, doctors are generally taught how to treat diseases with drugs (disease –> treatment) and they know the basics about vitamins, but they may not be aware of the powerful preventative effects that vitamins have on the body. Why would they, when they barely have enough time to see their patients in between their family life and visits with drug reps?

Try this the next time you are with your doctor. Ask them if they are aware of a strong link between high doses of vitamin C and vitamin E and a highly decreased incidence (occurrence) of Alzheimer Disease? If yours does, then you should be thankful that your doctor is more on top of things than most. Many doctor’s simply don’t know. Don’t let what they do not know hurt your body. Afterall, nobody else looks out for your well-being as much as you do.

Explore our Multivitamin Product Reference

A good multivitamin is the foundation of health and nutrition. Take a look at our scientific reviews of many of the popular brands for factors such as ingredients, areas of improvement, quality level, and overall value.

Originally posted here:

Vitamin Research – All the latest research on Vitamins A …

Recommendation and review posted by Alexandra Lee Anderson